Left ventricular volume and wall stress are linked to lung function impairment in COPD.
暂无分享,去创建一个
H. Watz | J. Vestbo | C. Vogelmeier | T. Welte | E. Wouters | S. Gläser | H. Schulz | A. Karch | R. Bals | R. Jörres | P. Alter | D. Young | David Young
[1] J. Hohlfeld,et al. Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial. , 2018, The Lancet. Respiratory medicine.
[2] J. Wedzicha,et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. , 2017, American journal of respiratory and critical care medicine.
[3] N. Eves,et al. Heart-lung interaction in a model of COPD: importance of lung volume and direct ventricular interaction. , 2016, American journal of physiology. Heart and circulatory physiology.
[4] N. Sverzellati,et al. Left ventricular structure and remodeling in patients with COPD , 2016, International journal of chronic obstructive pulmonary disease.
[5] R. Holle,et al. The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. , 2016, Respiratory medicine.
[6] S. Petersen,et al. Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. , 2016, American journal of respiratory and critical care medicine.
[7] A. Gemma,et al. COPD advances in left ventricular diastolic dysfunction , 2016, International journal of chronic obstructive pulmonary disease.
[8] A. Hofman,et al. Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study. , 2016, American journal of respiratory and critical care medicine.
[9] C. Vogelmeier,et al. Wall stress determines systolic and diastolic function--Characteristics of heart failure. , 2016, International journal of cardiology.
[10] J. Yim,et al. Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data , 2015, International journal of chronic obstructive pulmonary disease.
[11] Y. Oh,et al. Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease , 2015, International journal of chronic obstructive pulmonary disease.
[12] T. Greulich,et al. Airflow limitation in COPD is associated with increased left ventricular wall stress in coincident heart failure. , 2015, Respiratory medicine.
[13] J. Soriano,et al. Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. , 2015, The New England journal of medicine.
[14] R. Zuwallack,et al. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD , 2015, European Respiratory Review.
[15] R. Goldberg,et al. Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure: the Worcester Heart Failure Study. , 2015, Chest.
[16] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[17] M. Bottai,et al. Survival in COPD: Impact of Lung Dysfunction and Comorbidities , 2014, Medicine.
[18] Benjamin M. Smith,et al. Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study. , 2013, Chest.
[19] A. Agustí,et al. Cardiovascular comorbidity in COPD: systematic literature review. , 2013, Chest.
[20] S. Stanojevic,et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.
[21] K. Klose,et al. Increased end diastolic wall stress precedes left ventricular hypertrophy in dilative heart failure--use of the volume-based wall stress index. , 2012, International journal of cardiology.
[22] B. Nordestgaard,et al. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. , 2011, European heart journal.
[23] R Merget,et al. Body plethysmography--its principles and clinical use. , 2011, Respiratory medicine.
[24] H. Magnussen,et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. , 2010, Chest.
[25] Eric A. Hoffman,et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. , 2010, The New England journal of medicine.
[26] A. Chaouat,et al. Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases , 2009, Seminars in respiratory and critical care medicine.
[27] Mary B Wagner,et al. Stretch-activated channel activation promotes early afterdepolarizations in rat ventricular myocytes under oxidative stress. , 2009, American journal of physiology. Heart and circulatory physiology.
[28] S. Solomon,et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT) , 2009, European journal of heart failure.
[29] M. Decramer,et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.
[30] P. Calverley,et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. , 2008, American journal of respiratory and critical care medicine.
[31] K. Klose,et al. B-type natriuretic peptide and wall stress in dilated human heart , 2008, Molecular and Cellular Biochemistry.
[32] Konrad Schultz,et al. Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD) , 2007 .
[33] G. Viegi,et al. Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.
[34] Shinsuke Yuasa,et al. Analysis of the electrophysiological properties and arrhythmias in directly contacted skeletal and cardiac muscle cell sheets. , 2005, Cardiovascular research.
[35] J. Marcus,et al. Early changes of cardiac structure and function in COPD patients with mild hypoxemia. , 2005, Chest.
[36] E. Prescott,et al. Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study , 2003, European Respiratory Journal.
[37] V. Peinado,et al. Pulmonary hypertension in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[38] B. Hedblad,et al. Occurrence and Prognostic Significance of Ventricular Arrhythmia Is Related to Pulmonary Function: A Study From “Men Born in 1914,” Malmö, Sweden , 2001, Circulation.
[39] P. Bentler,et al. Cutoff criteria for fit indexes in covariance structure analysis : Conventional criteria versus new alternatives , 1999 .
[40] B. Celli,et al. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. , 1996, American journal of respiratory and critical care medicine.
[41] J E Cotes,et al. Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.
[42] P. Schnohr,et al. Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. , 1991, The European respiratory journal.
[43] W Grossman,et al. Cardiac hypertrophy: useful adaptation or pathologic process? , 1980, The American journal of medicine.
[44] A. Buda,et al. Effect of intrathoracic pressure on left ventricular performance. , 1979, The New England journal of medicine.